Satoshi Yoshiji

PhD candidate
McGill University/Broad Institute of MIT and Harvard
McGill University/Broad Institute of MIT and Harvard

Satoshi Yoshiji is a clinician-scientist with board certifications in Endocrinology and Internal Medicine. He is currently completing his PhD in Human Genetics at McGill University. His research focuses on leveraging human genomics and proteomics to identify drug targets for diabetes, obesity, and cardiovascular diseases. He is an incoming faculty member at the McGill University Department of Human Genetics.

Disclosure information not submitted.

Presentation(s):

• INTEGRATIVE PROTEOGENOMICS ANALYSIS IDENTIFIES COL6A3-DERIVED ENDOTROPHIN AS AN ACTIONABLE MEDIATOR OF THE EFFECT OF OBESITY ON CORONARY ARTERY DISEASE (CCC-230)

  Friday, October 27, 2023
  11:10 – 11:20 EST

• INTEGRATIVE PROTEOGENOMICS ANALYSIS IDENTIFIES COL6A3-DERIVED ENDOTROPHIN AS AN ACTIONABLE MEDIATOR OF THE EFFECT OF OBESITY ON CORONARY ARTERY DISEASE (VP066)

  Friday, October 27, 2023
  15:15 – 15:25 EST

• INTEGRATIVE PROTEOGENOMICS ANALYSIS IDENTIFIES COL6A3-DERIVED ENDOTROPHIN AS AN ACTIONABLE MEDIATOR OF THE EFFECT OF OBESITY ON CORONARY ARTERY DISEASE (CCC-172)

  Saturday, October 28, 2023
  10:15 – 10:25 EST